Research Analysts’ Recent Ratings Changes for DocuSign (DOCU)

A number of research firms have changed their ratings and price targets for DocuSign (NASDAQ: DOCU):

• 12/6/2024 – DocuSign had its price target raised by analysts at Wells Fargo & Company from $50.00 to $70.00. They now have an “underweight” rating on the stock.
• 12/6/2024 – DocuSign had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $90.00 price target on the stock, up previously from $57.00.
• 12/6/2024 – DocuSign had its “reduce” rating reaffirmed by analysts at HSBC Holdings plc.
• 12/6/2024 – DocuSign had its price target raised by analysts at UBS Group AG from $60.00 to $100.00. They now have a “neutral” rating on the stock.
• 12/6/2024 – DocuSign had its price target raised by analysts at Piper Sandler from $60.00 to $90.00. They now have a “neutral” rating on the stock.
• 12/6/2024 – DocuSign had its price target raised by analysts at Robert W. Baird from $59.00 to $100.00. They now have a “neutral” rating on the stock.
• 12/6/2024 – DocuSign was upgraded by analysts at Hsbc Global Res to a “moderate sell” rating.
• 12/6/2024 – DocuSign had its price target raised by analysts at JMP Securities from $108.00 to $124.00. They now have a “market outperform” rating on the stock.
• 12/6/2024 – DocuSign had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 12/6/2024 – DocuSign had its price target raised by analysts at Morgan Stanley from $62.00 to $97.00. They now have an “equal weight” rating on the stock.
• 12/6/2024 – DocuSign had its price target raised by analysts at Citigroup Inc. from $87.00 to $113.00. They now have a “buy” rating on the stock.
• 12/3/2024 – DocuSign had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $70.00. They now have an “underweight” rating on the stock.
• 12/3/2024 – DocuSign had its price target raised by analysts at Jefferies Financial Group Inc. from $80.00 to $95.00. They now have a “buy” rating on the stock.
• 11/22/2024 – DocuSign had its price target raised by analysts at JMP Securities from $84.00 to $108.00. They now have a “market outperform” rating on the stock.

DocuSign Price Performance

NASDAQ:DOCU opened at $94.85 on Wednesday. The firm has a market capitalization of $19.16 billion, a price-to-earnings ratio of 19.56, a PEG ratio of 8.72 and a beta of 0.92. The business has a 50 day simple moving average of $81.38 and a 200-day simple moving average of $65.16. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86.

Insider Activity

In other DocuSign news, CEO Allan C. Thygesen sold 7,648 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $62.47, for a total value of $477,770.56. Following the completion of the sale, the chief executive officer now directly owns 115,589 shares of the company’s stock, valued at $7,220,844.83. The trade was a 6.21 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total transaction of $50,516.40. Following the sale, the director now directly owns 7,736 shares of the company’s stock, valued at $731,825.60. This represents a 6.46 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 660,737 shares of company stock valued at $63,029,016. 1.66% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On DocuSign

Several institutional investors have recently made changes to their positions in DOCU. Itau Unibanco Holding S.A. bought a new position in DocuSign during the 3rd quarter worth about $28,000. Brooklyn Investment Group bought a new position in shares of DocuSign during the third quarter valued at approximately $33,000. Reston Wealth Management LLC purchased a new position in DocuSign during the third quarter valued at approximately $47,000. nVerses Capital LLC bought a new position in DocuSign in the second quarter worth approximately $48,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in DocuSign during the third quarter worth $51,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.